[1]Papatzimas,JamesW.;Gorobets,Evgueni;Maity,Ranjan;Muniyat,MirIshruna;Maccallum,JustinL.;Neri,Paola;Bahlis,NizarJ.;Derksen,DarrenJ.[JournalofMedicinalChemistry,2019,vol.62,#11,p.5522-5540]
[1]Papatzimas,JamesW.;Gorobets,Evgueni;Maity,Ranjan;Muniyat,MirIshruna;Maccallum,JustinL.;Neri,Paola;Bahlis,NizarJ.;Derksen,DarrenJ.[JournalofMedicinalChemistry,2019,vol.62,#11,p.5522-5540]
Title: Leverson JD, et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Cell Death Dis. 2015 Jan 15;6:e1590.
Title: Qing Wang, et al. A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML. Oncol Lett. 2019 Nov;18(5):5481-5489.